Bristol-Myers, Watson Settle Pravastatin Suit
The court overseeing a Novartis AG subsidiary's patent infringement suit against Bristol-Myers Squibb Co. and Watson Pharmaceuticals Inc. over the cholesterol-lowering medication pravastatin has signed off on a settlement agreement bringing...To view the full article, register now.
Already a subscriber? Click here to view full article